Disaccharide tripeptide glycerol dipalmitoyl

DB15423InvestigationalSmall molecule

Disaccharide tripeptide glycerol dipalmitoyl is under investigation in clinical trial NCT00003667 (Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma).

Formula / weight: C₆₅H₁₁₆N₆O₂₁ · 1317.664 g/mol (avg)

Resolves to

Compound

UNII6PHSP9EORVCAS130114-83-9

Structure

InChIKeyDNUXJWBKTMJNEP-JVSLBXKQSA-NSMILES

CCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)[C@H](C)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]([C@@H](NC(C)=O)C=O)[C@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O)[C@H](O)CO)C(N)=O)OC(=O)CCCCCCCCCCCCCCC

What you can answer from here — as of April 23, 2025

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of Disaccharide tripeptide glycerol dipalmitoyl, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account